Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|December 26, 2001
Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancerD Dworakowska, S Gózdz, E Jassem, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-arm randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)P F Bruning, J M Bonfrèr, J Wildiers, et al.
British Journal of Cancer|January 23, 2014
Prognostic value of microRNA expression in operable non-small cell lung cancer patientsM Skrzypski, P Czapiewski, K Goryca, et al.
Folia Neuropathologica|December 3, 1999
The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau diseaseB Wysocka, M Wełnicka-Jaśkiewicz, K Matuszewska, et al.
Oncology|January 1, 1992
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancerE Kánitz, K Kolaric, J Jassem, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1990
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG)S Eckhardt, K Kolaric, D Vukas, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2013
Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: final results of the Retreatment after HErceptin Adjuvant trialI Láng, R Bell, F Y Feng, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 9, 2006
Prognostic value of S-100 immunostaining in tumour cells of non-small cell lung cancerE Jassem, K Serkies, R Dziadziuszko, et al.
Lung Cancer (Amsterdam, Netherlands)|November 27, 2001
Types and localisation of p53 gene mutations: a report on 332 non-small cell lung cancer patientsE Jassem, J Nikliński, R Rosell, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II studyP Zatloukal, E Kanitz, P Magyar, et al.
Pageof 10